Published in:
Open Access
01-05-2021 | Rectal Cancer | Colorectal Cancer
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Authors:
Lucrezia D’Alimonte, MD, Quoc Riccardo Bao, MD, Gaya Spolverato, MD, Giulia Capelli, MD, Paola Del Bianco, MS, Laura Albertoni, MD, Antonino De Paoli, MD, Mario Guerrieri, MD, Giovanna Mantello, MD, Maria Antonietta Gambacorta, MD, Vincenzo Canzonieri, MD, Vincenzo Valentini, MD, Claudio Coco, MD, Salvatore Pucciarelli, MD
Published in:
Annals of Surgical Oncology
|
Issue 5/2021
Login to get access
Abstract
Background
Local excision might represent an alternative to total mesorectal excision for patients with locally advanced rectal cancer who achieve a major or complete clinical response after neoadjuvant chemoradiotherapy.
Methods
Between August 2005 and July 2011, 63 patients with mid-low rectal adenocarcinoma who had a major/complete clinical response after neoadjuvant chemoradiotherapy were enrolled in a multicenter prospective phase 2 trial and underwent transanal full thickness local excision. The main endpoint of this study was to evaluate the 5- and 10-year overall, relapse-free, local, and distant relapse-free survival, which were calculated by applying the Kaplan–Meier method. The rate of patients with rectum preserved and without stoma were also calculated.
Results
Of 63 patients, 38 (60%) were male and 25 (40%) were female, with a median (range) age of 64 (25–82) years. At baseline, the following clinical stages were found: cT2, n = 21 (33.3%); cT3, n = 42 (66.6%), 39 (61.9%) patients were cN+. At a median (range) follow-up of 108 (32–166) months, the estimated cumulative 5- and 10-year overall survival, relapse-free survival, local recurrence-free survival, and distant recurrence-free survival were 87% (95% CI 76–93) and 79% (95% CI 66–87), 89% (95% CI 78–94) and 82% (95% CI 66–91), both 91% (95% CI 81–96), and 90% (95% CI 80–95) and 86% (95% CI 73–93), respectively. Overall, 49 (77.8%) patients had their rectum preserved, and 54 (84.1%) were stoma-free.
Conclusion
In highly selected patients, the local excision approach after neoadjuvant chemoradiotherapy is associated with excellent long-term outcomes, high rates of rectum preservation and absence of permanent stoma.